XML 31 R20.htm IDEA: XBRL DOCUMENT
v3.20.2

Impairment of Long-Lived Assets | 6 Months Ended
--- | ---
Jun. 30, 2020
Impairment Or Disposal Of Tangible Assets Disclosure [Abstract] |
Impairment of Long-Lived Assets |
13. | Impairment of Long-Lived Assets
Due to the temporary closure of the Company’s theatres effective March 18, 2020 as a result of the COVID-19 pandemic (see Note 2), the Company performed a long-lived asset impairment evaluation for all theatres during the three months ended March 31, 2020. The impairment evaluation was based on the estimated undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. Significant judgment, including management’s estimate of the impact of temporary theatre closures and other considerations as a result of COVID-19, was involved in estimating cash flows and fair value. Fair value is determined based on a multiple of cash flows, which was six times for the evaluations performed. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy, as defined by FASB ASC Topic 820-10-35, are based on projected operating performance, market transactions and industry trading multiples. The Company performed a qualitative impairment analysis on its long-lived assets as of June 30, 2020, considering the timing of expected theatre reopenings on its estimated cash flows as well as market transactions and industry trading multiples. As a result of the qualitative assessment, no impairment of long-lived assets was recorded during the three months ended June 30, 2020. Below is a summary of impairment charges for the periods presented:
|  | Three Months Ended |  |  | Six Months Ended |
|  | June 30, |  |  | June 30, |
|  | 2020 |  |  | 2019 |  |  | 2020 |  |  | 2019 |
U.S. Segment |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Theatre properties |  | $ | — |  |  | $ | 1,044 |  |  | $ | 3,643 |  |  | $ | 2,252 |
Theatre operating lease right-of-use assets |  |  | — |  |  |  | 8,047 |  |  |  | 5,952 |  |  |  | 8,047 |
U.S. total |  |  | — |  |  |  | 9,091 |  |  |  | 9,595 |  |  |  | 10,299 |
International segment |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Theatre properties |  |  | — |  |  |  | 1,775 |  |  |  | 4,484 |  |  |  | 6,151 |
Theatre operating lease right-of-use assets |  |  | — |  |  |  | 1,628 |  |  |  | 2,540 |  |  |  | 1,628 |
International total |  |  | — |  |  |  | 3,403 |  |  |  | 7,024 |  |  |  | 7,779 |
Total Impairment |  | $ | — |  |  | $ | 12,494 |  |  | $ | 16,619 |  |  | $ | 18,078 |

X
- Definition The entire disclosure for the details of the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value. Disclosure may also include a description of the impaired asset and facts and circumstances leading to the impairment, amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired asset is reported. + References No definition available. + Details
Name: | us-gaap_AssetImpairmentChargesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ImpairmentOrDisposalOfTangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration